BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 42 filers reported holding BIND THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | -91.7% | 1,685 | -89.3% | 0.00% | – |
| Q4 2015 | $36,000 | – | 15,781 | +36600.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 43 | -99.9% | 0.00% | – |
| Q2 2015 | $166,000 | +514.8% | 29,744 | +485.9% | 0.00% | – |
| Q1 2015 | $27,000 | -28.9% | 5,077 | -28.5% | 0.00% | – |
| Q4 2014 | $38,000 | -80.7% | 7,100 | -52.6% | 0.00% | – |
| Q2 2014 | $197,000 | +756.5% | 14,971 | +644.1% | 0.00% | – |
| Q1 2014 | $23,000 | -94.0% | 2,012 | -92.1% | 0.00% | – |
| Q4 2013 | $385,000 | – | 25,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 155,000 | $2,123,500,000 | 1.67% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,207 | $8,426,000 | 0.50% |
| BVF INC/IL | 150,000 | $2,264,000 | 0.40% |
| EMERALD ADVISERS, LLC | 419,752 | $6,334,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,384 | $3,869,000 | 0.20% |
| Alyeska Investment Group, L.P. | 62,087 | $937,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $23,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 13,000 | $196,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 23,580 | $356,000 | 0.03% |
| TFS CAPITAL LLC | 20,933 | $316,000 | 0.02% |